scispace - formally typeset
A

Anders Björklund

Researcher at Lund University

Publications -  771
Citations -  87172

Anders Björklund is an academic researcher from Lund University. The author has contributed to research in topics: Transplantation & Dopamine. The author has an hindex of 165, co-authored 769 publications receiving 84268 citations. Previous affiliations of Anders Björklund include University of Washington & Institute for the Study of Labor.

Papers
More filters
Journal ArticleDOI

NGF improves spatial memory in aged rodents as a function of age

Walter Fischer, +3 more
- 01 Jul 1991 - 
TL;DR: NGF-infused rats showed improved retention of previously acquired place navigation performance and improved spatial acuity over the former platform site when the invisible platform was removed and NGF infusion also had a significant effect in the much more severely impaired 30-month-old rats.
Book

Functional neural transplantation

Stephen B. Dunnett, +1 more
TL;DR: In this volume, leading international experts review the present status of all major areas of research in functional neural transplantation and assess the capacity of neural grafts to repair the structural damage and alleviate the functional consequences of brain damage and neurodegenerative disease.
Journal ArticleDOI

Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons

Martin Lundblad, +3 more
- 28 Feb 2012 - 
TL;DR: The early changes in synaptic DA release induced by overexpression of human α-synuclein support the idea that early predegenerative changes in the handling of DA may initiate, and drive, a progressive degenerative process that hits the axons and terminals first.
Journal ArticleDOI

Cell transplantation in Parkinson's disease: how can we make it work?

Christian Winkler, +2 more
- 01 Feb 2005 - 
TL;DR: The problems raised by the NIH-sponsored trials are discussed and several shortcomings that might explain the overall poor outcome are pointed to.
Journal ArticleDOI

Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle

Carl Rosenblad, +5 more
- 01 May 1999 - 
TL;DR: GDNF is highly effective as a neuroprotective and axon growth‐stimulating agent in the IS 6‐OHDA lesion model after both IS and ICV administration, and the lower efficacy of NTN after IS, and particularly ICV, administration may be explained by the poor solubility and diffusion properties at neutral pH.